Sign In
Buy ARCT
$7.60
-0.0500 (-0.654%)
At Close: Jun 03, 2026
Nurses Union Knocks on SC Door, Seeks Directions on PPE, Salaries and Accommodation
12:10pm, Monday, 15'th Jun 2020
In their intervention application, the nurses' union sought formulation of a national Covid-19 management protocol for addressing the serious concerns relating to imminent and extreme risks to workers
The
CDL-BH e Fiemg firmam parceria para ajudar micro e pequena empresa
04:30pm, Sunday, 14'th Jun 2020
A partir desta segunda-feira (15), uma equipe de suporte estar
Marktbeeld 12 juni 2020
12:00am, Friday, 12'th Jun 2020
Markt Overzicht door Beursbox.nl (Tom Lassing) over: Dow Jones Industrial Average, Unilever NV. Lees Beursbox.nl (Tom Lassing)'s Markt Overzicht op Investing.com.
Adam Gilchrist lauds efforts of Indian nurse in Australia amid COVID-19 crisis
04:58pm, Thursday, 11'th Jun 2020
Adam Gilchrist gave a shout-out to Indian nurse Sharon Varghese, who has been working in Wollongong as a care-worker.
Arcturus Therapeutics to Present at the Raymond James Human Health Innovation Virtual Conference
12:00pm, Thursday, 11'th Jun 2020
SAN DIEGO, June 11, 2020 -- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on.
Stocks in Europe skid as reversal from rally continues
07:26am, Thursday, 11'th Jun 2020
European stocks slumped Thursday in early trade, losing ground for a fourth session as traders looked for a new catalyst after the breathtaking rally from...
Singapore boosting capacity for fast Covid-19 vaccine production
09:00pm, Friday, 05'th Jun 2020
Singapore is building up vaccine manufacturing capacity so production can be ramped up quickly and safely once a Covid-19 vaccine is found.. Read more at straitstimes.com.
SAN DIEGO, June 05, 2020 -- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on.
After Plummeting Over 30%, Are Arcturus Therapeutics Shares Still a Good Buy?
11:27am, Thursday, 04'th Jun 2020
Arcturus Therapeutics' (NASDAQ: ARCT) stock saw deep losses on May 27, in part because of spillover from news about patients in Moderna's (NASDAQ: MRNA) COVID-19 vaccine trial experiencing adverse re
Cramer Shares His Thoughts On UBS, Alteryx And More
12:11pm, Wednesday, 03'rd Jun 2020
On CNBC's "Mad Money Lightning Round," Jim Cramer said he's not going to recommend Ares Capital Corporation (NASDAQ: ARCC). He doesn't know what are its investments.UBS Group AG (NYSE: UBS) doesn't ha
Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine
06:11pm, Thursday, 28'th May 2020
When I first started buying ARCT shares I didn't conceive of a valuation of $1 billion, but I also didn't conceive of the global impact of a pandemic.
Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine
06:11pm, Thursday, 28'th May 2020
When I first started buying ARCT shares I didn't conceive of a valuation of $1 billion, but I also didn't conceive of the global impact of a pandemic.
Why Arcturus Therapeutics Stock Is Plunging Today
04:35pm, Wednesday, 27'th May 2020
Shares of Arcturus Therapeutics (NASDAQ: ARCT) were plunging 32.3% as of 11:43 a.m. EDT on Wednesday. Reports surfaced yesterday that one of the participants in Moderna's phase 1 study of its COVID-1
New Coronavirus Vaccine To Send Virus' Spike Protein To Activate Body's Immune Response
12:00pm, Tuesday, 26'th May 2020
Novavax is now beginning its clinical trials.
